Give us a call
614-334-4944
Approved in 2021 by the FDA for chronic weight management in obese/overweight adults, this injection has been described as a “game changer” in medical weight loss. Semaglutide is a GLP-1 agonist and works by increasing insulin release, lowering the amount of glucagon released, delaying gastric emptying and reducing appetite. In combination with BPC-157, (Body Protection Compound) a peptide chain based on a protective compound present in the human stomach, BPC-157 works by triggering the formation of new blood vessels (angiogenesis.) This promotes healing and induces faster regeneration of cells.
On average, our patients experience a 2-3 pound weekly weight loss. If you’re ready to take the next step towards optimal health, we offer Free virtual/phone consultations with our nurse practitioner, Stephanie.